Hero MotoCorp (NSE: HEROMOTOCO) May dispatches rise to 5.7 lakh units as VIDA and exports sharpen growth story
Read More Pharma Industry News How Persevere Therapeutics plans to reposition misetionamide in a crowded ovarian cancer pipeline Persevere Therapeutics launches misetionamide ovarian cancer trial. Discover how its strategy could reshape treatment competition. bySoujanya RaviMarch 6, 2026